Two Novel Mutations of the TSH-β Subunit Gene Underlying Congenital Central Hypothyroidism Undetectable in Neonatal TSH Screening
- 1 September 2010
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 95 (9), E98-E103
- https://doi.org/10.1210/jc.2010-0223
Abstract
Context: Patients with TSH-beta subunit defects and congenital hypothyroidism are missed by TSH-based neonatal screening. Objective: Our objective was to report the molecular consequences of a novel splice-junction mutation and a novel missense mutation in the TSH-beta subunit gene found in two patients with congenital central hypothyroidism and conventional treatment-resistant anemia. Results: Patient 1 had a homozygous G to A nucleotide change at the 5' donor splice site of exon/intron 2. This resulted in a silent change at codon 34 of the mature protein. In vitro splicing assays showed that the mutant minigene dramatically affected pre-mRNA processing, causing exon 2 to be completely skipped. The putative product from a new out-of-frame translational start point in exon 3 is expected to yield a nonsense 25-amino-acid peptide. In patient 2, sequence analysis revealed a compound heterozygosis for the already reported 313delT (C105Vfs114X) mutation and for a second novel mutation in exon 3, substituting G for A at cDNA nucleotide position 323, resulting in a C88Y change. This cysteine residue is conserved among all dimeric pituitary and placental glycoprotein hormone-beta subunits. Data from in silico analysis confirmed that the C88Y mutation would affect subunit conformation. Indeed, two different bioinformatics approaches, PolyPhen and SIFT analysis, predicted C88Y to be a damaging substitution. Conclusions: In isolated TSH deficiency, the exact molecular diagnosis is mandatory for diagnosis of isolated pituitary deficiency, delineation of prognosis, and genetic counseling. Moreover, diagnosis of central hypothyroidism should be considered in the face of severe infant anemia of uncertain etiology. (J Clin Endocrinol Metab 95: E98-E103, 2010)This publication has 8 references indexed in Scilit:
- The cytochrome P450 aromatase lacking exon 5 is associated with a phenotype of nonclassic aromatase deficiency and is also present in normal human steroidogenic tissuesClinical Endocrinology, 2007
- Splicing in action: assessing disease causing sequence changesJournal of Medical Genetics, 2005
- Compound Heterozygous and Homozygous Mutations of the TSHβ Gene as a Cause of Congenital Central Hypothyroidism in EuropeHormone Research in Paediatrics, 2004
- Four New Cases of Congenital Secondary Hypothyroidism due to a Splice Site Mutation in the Thyrotropin-? Gene: Phenotypic Variability and Founder EffectJournal of Clinical Endocrinology & Metabolism, 2004
- The C105fs114X Is the Prevalent Thyrotropin Beta-Subunit Gene Mutation in Argentinean Patients with Congenital Central HypothyroidismHormone Research in Paediatrics, 2004
- Neonatal Thyroid DisordersHormone Research in Paediatrics, 2003
- Low TSH Congenital Hypothyroidism: Identification of a Novel Mutation of the TSH beta-Subunit Gene in One Sporadic Case (C85R) and of Mutation Q49stop in Two Siblings with Congenital HypothyroidismPediatric Research, 2002
- Congenital Central Hypothyroidism due to Homozygous Thyrotropin β 313ΔT Mutation Is Caused by a Founder EffectJournal of Clinical Endocrinology & Metabolism, 2002